Zealand Pharma completes registration of capital increase By Investing.com
Company announcement “ No. 36 / 2024 Zealand Pharma (NASDAQ:) completes registration of capital increase NOT FOR RELEASE, PUBLICATION OR ...
Company announcement “ No. 36 / 2024 Zealand Pharma (NASDAQ:) completes registration of capital increase NOT FOR RELEASE, PUBLICATION OR ...
Genügend Zeit für einen Swingtrade bis zu den Quartalszahlen. Jetzt einsteigen bei der Palantir-Aktie (PLTR)? Endlich in der Gewinnzone! Palantir ...
Vials on the Wegovy line at the Novo Nordisk A/S production facilities in Hillerod, Denmark, on Friday, March 8, 2024. Bloomberg ...
Aurobindo Pharma (NS:) has outperformed expectations in the fourth quarter of FY24, with both sales and EBITDA showing significant year-over-year ...
Benchmark indices closed higher on Wednesday amid buying in blue chips even on the back of mixed cues from global ...
Innate Pharma SA (OTC:) (IPHA) discussed its first quarter 2024 financial results and provided a business update during a recent ...
On Friday, BofA Securities updated its outlook on Tarsus Pharmaceuticals (NASDAQ:TARS) shares, increasing the price target to $63 from $60 ...
Inozyme Pharma press release (NASDAQ:INZY): Q1 GAAP EPS of -$0.38 beats by $0.02. Cash, cash equivalents, and short-term investments were ...
"However, on the largecap side, the valuations are not so expensive. It is just about 5% or 6% higher than ...
MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (OTC:) (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company) today announced that ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.